Satellos Bioscience Inc.

MSCLF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$28-$16-$11-$16
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$0
Stock-Based Comp.$2$2$1$1
Change in WC-$1$0$1-$0
Other Non-Cash$2-$1$3$10
Operating Cash Flow-$25-$15-$6-$5
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$2
Inv. Purchases-$37-$18$0$0
Inv. Sales/Matur.$44$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$6-$18-$0$2
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$43$32$2$7
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$11$51$3$7
Financing Cash Flow$53$51$3$7
Forex Effect$1$1-$0-$0
Net Chg. in Cash$36$0-$3$4
Supplemental Information
Beg. Cash$22$2$5$1
End Cash$58$22$2$5
Free Cash Flow-$25-$15-$6-$5